AXGN
Price
$16.25
Change
+$0.07 (+0.43%)
Updated
Apr 29, 02:14 PM (EDT)
Capitalization
348.67M
9 days until earnings call
HOCPF
Price
$120.19
Change
+$8.01 (+7.14%)
Updated
Apr 28 closing price
Capitalization
41.52B
Ad is loading...

AXGN vs HOCPF

Header iconAXGN vs HOCPF Comparison
Open Charts AXGN vs HOCPFBanner chart's image
Axogen
Price$16.25
Change+$0.07 (+0.43%)
Volume$100
Capitalization348.67M
Hoya
Price$120.19
Change+$8.01 (+7.14%)
Volume$1.11K
Capitalization41.52B
AXGN vs HOCPF Comparison Chart
Loading...
AXGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXGN vs. HOCPF commentary
Apr 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXGN is a Buy and HOCPF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 29, 2025
Stock price -- (AXGN: $16.18 vs. HOCPF: $120.19)
Brand notoriety: AXGN and HOCPF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AXGN: 38% vs. HOCPF: 104%
Market capitalization -- AXGN: $348.67M vs. HOCPF: $41.52B
AXGN [@Medical Specialties] is valued at $348.67M. HOCPF’s [@Medical Specialties] market capitalization is $41.52B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXGN’s FA Score shows that 0 FA rating(s) are green whileHOCPF’s FA Score has 0 green FA rating(s).

  • AXGN’s FA Score: 0 green, 5 red.
  • HOCPF’s FA Score: 0 green, 5 red.
According to our system of comparison, AXGN is a better buy in the long-term than HOCPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXGN’s TA Score shows that 5 TA indicator(s) are bullish.

  • AXGN’s TA Score: 5 bullish, 5 bearish.

Price Growth

AXGN (@Medical Specialties) experienced а +6.59% price change this week, while HOCPF (@Medical Specialties) price change was +12.26% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +5.58%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

AXGN is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Medical Specialties (+5.58% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HOCPF($41.5B) has a higher market cap than AXGN($349M). HOCPF YTD gains are higher at: -1.563 vs. AXGN (-1.820). HOCPF has higher annual earnings (EBITDA): 267B vs. AXGN (-13.33M). HOCPF has more cash in the bank: 426B vs. AXGN (31M). AXGN has less debt than HOCPF: AXGN (69.3M) vs HOCPF (24.6B). HOCPF has higher revenues than AXGN: HOCPF (734B) vs AXGN (159M).
AXGNHOCPFAXGN / HOCPF
Capitalization349M41.5B1%
EBITDA-13.33M267B-0%
Gain YTD-1.820-1.563116%
P/E RatioN/A35.97-
Revenue159M734B0%
Total Cash31M426B0%
Total Debt69.3M24.6B0%
FUNDAMENTALS RATINGS
AXGN vs HOCPF: Fundamental Ratings
AXGN
HOCPF
OUTLOOK RATING
1..100
1959
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
52
Fair valued
PROFIT vs RISK RATING
1..100
6764
SMR RATING
1..100
91100
PRICE GROWTH RATING
1..100
4061
P/E GROWTH RATING
1..100
10075
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AXGN's Valuation (47) in the Medical Specialties industry is in the same range as HOCPF (52) in the null industry. This means that AXGN’s stock grew similarly to HOCPF’s over the last 12 months.

HOCPF's Profit vs Risk Rating (64) in the null industry is in the same range as AXGN (67) in the Medical Specialties industry. This means that HOCPF’s stock grew similarly to AXGN’s over the last 12 months.

AXGN's SMR Rating (91) in the Medical Specialties industry is in the same range as HOCPF (100) in the null industry. This means that AXGN’s stock grew similarly to HOCPF’s over the last 12 months.

AXGN's Price Growth Rating (40) in the Medical Specialties industry is in the same range as HOCPF (61) in the null industry. This means that AXGN’s stock grew similarly to HOCPF’s over the last 12 months.

HOCPF's P/E Growth Rating (75) in the null industry is in the same range as AXGN (100) in the Medical Specialties industry. This means that HOCPF’s stock grew similarly to AXGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AXGN
RSI
ODDS (%)
Bullish Trend 2 days ago
60%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
AXGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GII64.270.32
+0.50%
SPDR® S&P® Global Infrastructure ETF
RYLG19.910.08
+0.41%
Global X Russell 2000 Cov Cl & Gr ETF
IMCG71.380.17
+0.24%
iShares Morningstar Mid-Cap Growth ETF
POWA80.910.17
+0.22%
Invesco Bloomberg Pricing Power ETF
NUAG20.880.03
+0.13%
Nuveen Enhanced Yield US Aggt Bd ETF

AXGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXGN has been loosely correlated with TCMD. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if AXGN jumps, then TCMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXGN
1D Price
Change %
AXGN100%
-1.34%
TCMD - AXGN
43%
Loosely correlated
-2.81%
TMDX - AXGN
38%
Loosely correlated
-3.54%
ICUI - AXGN
38%
Loosely correlated
+0.18%
XRAY - AXGN
37%
Loosely correlated
+0.87%
CLPT - AXGN
36%
Loosely correlated
+0.07%
More

HOCPF and

Correlation & Price change

A.I.dvisor tells us that HOCPF and AXGN have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HOCPF and AXGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOCPF
1D Price
Change %
HOCPF100%
+7.14%
AXGN - HOCPF
25%
Poorly correlated
-1.34%
HOCPY - HOCPF
25%
Poorly correlated
+1.48%
SHWGY - HOCPF
24%
Poorly correlated
-1.69%
TIVC - HOCPF
20%
Poorly correlated
-9.13%
FZMD - HOCPF
4%
Poorly correlated
N/A
More